DO WE USE METHYLATION OF NFATC1 AND FOS GENES AS A BIOMARKER FOR POSTMENOPAUSAL OSTEOPOROSIS?
Kalkan R, Tosun O
*Corresponding Author: Associate Professor Rasime Kalkan, Department of Medical Genetics, Faculty of Medicine, Near East University, Near East Boulevard, Nicosia, Cyprus, 99138. Tel: +903-92- 223-6464. Fax: +903-92-223-6461. E-mail: rasime.kalkan@neu.edu.tr, kalkanr@yahoo.com
page: 35

MATERIALS AND METHODS

The study protocol was approved by the Near East University Local Ethics Committee [YDU/2016/42-352], Nicosia, Cyprus. Written informed consent was obtained from all participants. Genomic DNA was extracted from blood samples according to the AllPrep DNA/RNA/Protein (Qiagen GmbH, Hilden, Germany) isolation kit, and its quantity was measured using a NanoDrop ND-1000 Spec-trophotometer (Thermo Fisher Scientific, Waltham, MA USA) [19]. Subjects. In this study, the subjects were divided into two groups. One group consisted of 35 postmenopausal women with a mean age of 56.7 ± 4.9, and the other group consisted of 30 premenopausal women with a mean age of 33.5 ± 6.9. None of the participants had hypertension, liver, kidney, diabetes, thyroid or cardiovascular disease. Medical therapy history was obtained for all subjects. They did not receive any medications or participate in any dietary or exercise program during the study. All participants were genetically unrelated postmenopausal females. Subjects with abnormal menopause, took medications such as anxiolytics, anti-depressants and/ or exogenous hormone. Women who had serious disease or mental retardation, smoking, alcohol usage and had weight loss therapy, food allergies, heart disease history, insulin-dependent diabetes mellitus type 2 (T2DM), kidney disease or liver disease, were excluded. Individuals who had been in postmenopause for a minimum of 1 year were recruited. Determination of NFATC1 and FOS Methylation Status. Bisulfite modification was applied according to the manufacturer’s protocol (EpiTect Bisulfite Kit; Qiagen GmbH) and 1.3 μg DNA was used for bisulfite treatment reaction. The Rotor Gene Q (Qiagen GmbH) was used for methylation sensitive-high resolution melting (MS-HRM) analysis to detect the methylation status of NFATC1 and FOS genes, and universal methylated and unmethylated DNA (EpiTect Control DNA Set, Cat No. 59568; Qiagen GmbH) was also used as a control in each reaction. The primers for each were designed according to the EpiTect® HRM™ PCR Handbook (Qiagen GmbH) [19]. Statistical analysis. The statistical analyses and their associations with patient characteristics were performed by Pearson’s χ2 test and two-tailed Fisher’s exact test. Calculations were performed using the Statistical Package for Social Science (SPSS) version 16.0 software (SPSS Inc., Chicago, IL, USA), and a p level of 0.05 was considered to be statistically significant.



Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006